C

CorMedix
D

CRMD

11.640
USD
0.05
(0.39%)
مغلق
حجم التداول
0
الربح لكل سهم
1
العائد الربحي
-
P/E
47
حجم السوق
866,355,492
الأفكار والتحليلات
هشام منسي
هشام منسي
منذ 9 أشهر
buy
2024-10-03 07:52
CRMD Chart
المزيد
أصول ذات صلة
A
AGEN
0.46000
(8.36%)
5.96000 USD
A
AKBA
-0.00500
(-0.14%)
3.61500 USD
C
CLRB
-0.04000
(-0.84%)
4.71000 USD
D
DVAX
0.095
(0.94%)
10.250 USD
M
MDGL
-2.26
(-0.75%)
298.20 USD
R
RDHL
-0.04000
(-1.96%)
2.00000 USD
R
RMTI
-0.00030
(-0.04%)
0.83000 USD
S
SNDX
0.01500
(0.17%)
9.01000 USD
المزيد
الأخبار المقالات

العنوان: CorMedix

القطاع: Healthcare
الصناعة: Biotechnology
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States (U.S.) and other key markets. The group currently operates in a single segment, Drug Product, located in a single geographic location, the United States.